Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis

American Journal of Tropical Medicine and Hygiene

Volumn 56, Issue 2, 1997, Pages 137-140

  Fryauff, David J ^a   Baird, J Kevin ^b   Purnomo, ^a   Awalludin, Mochammad ^a   Jones, Trevor ^a   Subianto, Budi ^c   Richte, Thomas L ^a   Tjitra, Emiliana ^d   Wignall, F Stephen ^a   Hoffman, Stephen L ^b  

^a US Nav Med Research Unit No 2   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^c Provincial Health Service   (Indonesia)

^d NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DOXYCYCLINE; PRIMAQUINE; QUININE SULFATE;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SENSITIVITY; ENDEMIC DISEASE; FOLLOW UP; HUMAN; IMMUNITY; INDONESIA; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RANDOMIZED CONTROLLED TRIAL;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 0030899540     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.56.137     Document Type: Article

References (17)

1. Thong YH, Ferrante A, Rowan-Kelly B, 1978. Primaquine inhibits mitogen-induced human lymphocyte proliferative responses. Trans R Soc Trop Med Hyg 72: 537-539.
2. Greval RS, 1981. Pharmacology of 8-aminoquinolines. Bull World Health Organ 59: 397-406.
3. Peters W, 1987. The chemotherapy-immunity interface. Chemotherapy and Drug Resistance in Malaria. Volume 2. Orlando FL: Academic Press, 893-919.
4. Fryauff DJ, Baird JK, Basri H, Sumawinata I, Purnomo, Richie TL, Ohrt CK, Mouzin E, Church CJ, Richards AL, Subianto B, Sandjaya B, Wignall FS, Hoffman SL, 1995. Randomized, placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 346: 1190-1193.
5. Selvin S, 1991. Life tables: an introduction. Monogr Epidemiol Biostat 17: 241-277.
6. Norman GR, Streiner DL, 1994. Biostatistics, the Bare Essentials. New York: Mosby, Inc.
7. Salmeron G, Lipsky PE, 1983. Immunosuppressive potential of antimalarials. Am J Med 75: 19-24.
8. Taylor DPJ, Wasi C, Bernard K, 1984. Chloroquine prophylaxis associated with a poor antibody response to human diploid cell rabies vaccine. Lancet i: 1405.
9. Bygbjerg IC, Flachs H, 1986. Effect of chloroquine on human lymphocyte proliferation. Trans R Soc Trop Med Hyg 80: 231-235.
10. Pappaioanou M, Fishbein MB, Dreesen DW, Schwartz IK, Campbell GH, Sumner JW, Patchen LC, Brown WJ, 1986. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med 314: 280-284.
11. Fryauff DJ, Richards AL, Baird JK, Richie TL, Mouzin E, Tjitra E, Sutamihardja MA, Ratiwayanto S, Hadiputranto H, Larasati RP, Pudjoprawoto N, Subianto B, Hoffman SL, 1996. Lymphocyte proliferation response and subset profiles during extended periods of chloroquine or primaquine prophylaxis. Antimicrob Agents Chemotherap: (in press).
12. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beuder E, Flanagan CL, Jeffery GM, 1955. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama P-F-6 strain). J Lab Clin Med 46: 391-397.
13. Schmidt LH, Fradkin R, Genther CS, Hughes HB, 1982. Delineation of the potentials of primaquine as a radical curative and prophylactic drug. Am J Trop Med Hyg 31: 66-680.
14. Clyde DF, McCarthy VC, 1977. Radical cure of Chesson strain vivax malaria in man by 7, not 14 days of treatment with primaquine. Am J Trop Med Hyg 26: 562-563.
15. Rombo L, Edwards G, Ward SA, Eriksson G, Lindquist L, Lindberg A, Runehagen A, Bjorkman A, Hylander NO, 1987. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop Med Parasitol 38: 49-50.
16. Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ, 1994. Blood-stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 169: 932-935.
17. Baird JK, Sismadi P, Masbar S, Ramzan A, Purnomo BW, Sekartuti, Tjitra E, Rumoko BW, Arbani PR, 1996. A focus of endemic malaria in Central Java. Am J Trop Med Hyg 54: 98-104.